Botox®, Aesthetics and Medical Weight Management Training for Physicians, Nurse Practitioners & Physician Assistants

Join 10,000+ medical providers who wanted to recession-proof their income and made a switch. Make more, work less and create dependable, recurring revenue with training to start your own profitable aesthetics practice.

Xeomin® Training for Physicians

Xeomin training

The number one most requested aesthetic procedure is for Botulinum Toxin (Botox®) injections.  Merz Aesthetics offers a competitor to Botox® – Xeomin®.  Xeomin® comes in 100 unit vials just like Botox® and behaves the same way as Botox®. For more information on Xeomin® for cosmetic patients, check out our information sheet.

The International Association for Physicians in Aesthetic Medicine (IAPAM) provides physicians (MD/DO’s), PAs, and NPs with comprehensive hands-on Xeomin® injection training led by board-certified cosmetic dermatologists.

The IAPAM’s offers the only Xeomin® injection training program course, where:

  • Injections are done in a CLEAN medical practice (per FDA), NOT a hotel room.
  • You will receive certification from the IAPAM, an internationally recognized medical association.
  • Designed by Physicians for Physicians
  • Training is lead by a board certified dermatologist (see our complete faculty)

Learn how to start and grow a profitable and successful aesthetics practice at our exclusive Aesthetic Medicine Symposium.

March 3-6, 2023 in sunny Scottsdale, AZ

Register today

Xeomin® Information

Executive Summary

  • Xeomin is available in the US as a treatment of glabellar lines
  • The main difference between Xeomin and Botox or Dysport, is that Xeomin contains just one ingredient: botulinum toxin A.
  • Xeomin is a “naked injectable,” meaning that it does not contain any additives. A benefit of a pure-form injectable is that the human body is less likely to become resistant to it.
  • Xeomin is the only one of the three (Xeomin, Botox and Dysport) that does not need to be refrigerated before use.
  • The cost of Xeomin is roughly the same as for Botox.
  • Xeomin has a similar “onset” of action (3-4 days) as Botox.
  • Xeomin may be “mildly more convenient” than Botox or Dysport, as the “product’s lack of complex proteins will help prevent antibody formation, or resistance to neuromuscular treatment with botulinum type A toxin, in patients being treated for neuromuscular conditions.”

Xeomin has available outside the US since 2005, and was introduced in the US in 2010.  Xeomin was given the FDA approval in July 2011 for the treatment of cervical dystonia, blepharospasm, and glabellar lines, but an injuction halted the release. 

Now, after a 10 month injunction, Xeomin is again being launched in the US as a treatment of glabellar lines.  Xeomin®, by Merz Pharmaceuticals LLC, is a competitor to the well established Botox Cosmetic® and lesser used Dysport®.

Patients are less likely to become resistant to Xeomin because there are simply less ingredients in the solution. Some patients have developed antibodies to Botox and Dysport.

Instructions for Preparation, Dosage and Administration

Xeomin is supplied in vials containing 50 or 100 Units of incobotulinumtoxinA, 1 mg of human albumin, and 4.7 mg sucrose. Xeomin should be reconstituted with sterile, preservative-free 0.9% Sodium Chloride Injection, USP.  

Reconstituted XEOMIN solution should be administered within 24 hours after dilution.  During this time period, reconstituted XEOMIN should be stored in a refrigerator 2-8°C (36-46°F).

Xeomin does not need to be refrigerated prior to reconstitution and has a shelf life of 3 years.

Reconstitution instructions are provided for both vial volumes:

Volume of Preservative-free 0.9% Sodium Chloride Injection, USP

50 Unit Vial:  Resulting dose in   Units per 0.1 mL

100 Unit Vial:  Resulting does   in Units per 0.1 mL

0.25 mL

20 Units

0.5 mL

10 Units

20 Units

1 mL

5 Units

10 Units

1.25 mL

4 Units

8 Units

2 mL

2.5 Units

5 Units

2.5 mL

2 Units

4 Units

4 mL

1.25 Units

2.5 Units

5 mL

1 Unit

2 Units

8 mL

1.25 Units

Re-treatment with XEOMIN should be administered no more frequently than every three months.

A suitable sterile needle 30-33 gauge (0.3-0.2 mm diameter), 13 mm length should be used in the administration in the treatment of glabellar lines.

The median first onset of XEOMIN effect occurs within seven days after injection. The typical duration of effect of each treatment is 3-4 months, but effects can last up to 6 months.


The cost for Xeomin is reported to be slightly less, but roughly the same as the cost of Botox®.*

It is anticipated that the average retail cost to a patient in the US, for a Xeomin treatment, is between $100.00 – $600.00 every 3-4 months.  It is dependent on the areas treated.

Leave Burnout in 2022 - It's Time to Switch

Join +10,000 MDs/DOs, PAs and NPs from all medical specialties who have successful secured their financial future with our Successful Aesthetic Practice System™ at the Aesthetic Medicine Symposium.

January 20-23
Only 2 spots left!
Scottsdale, Arizona

Not ready for live hands-on training? Start with our online certificates with the IAPAM Learning Lab. View courses.

Botox is a trademark of Allergan Inc.; Dysport is a trademark of Galderma; Xeomin is a trademark of Merz Aesthetics 

Best practices for injecting botox ebook



Emerging Trends, Expert Discussions, Recommendations, Technique Comparisons




Emerging Trends, Expert Discussions, Recommendations, Technique Comparisons